Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James V Freeman

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Medical Devices (Auckland, N.Z.)|September 2, 2017
Can machine learning complement traditional medical device surveillance? A case study of dual-chamber implantable cardioverter-defibrillatorsJoseph S Ross, Jonathan Bates, Craig S Parzynski, et al.
The American Journal of Cardiology|February 4, 2021
Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry)Manan Pareek, Avinainder Singh, Lina Vadlamani, et al.
Circulation. Arrhythmia and Electrophysiology|April 17, 2020
Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AFBenjamin A Steinberg, DaJuanicia N Holmes, Karen Pieper, et al.
The American Journal of Cardiology|August 23, 2020
Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)Malini Madhavan, DaJuanicia N Holmes, Jonathan P Piccini, et al.
Circulation. Arrhythmia and Electrophysiology|December 14, 2019
Outcomes and Anticoagulation Use After Catheter Ablation for Atrial FibrillationJames V Freeman, Peter Shrader, Karen S Pieper, et al.
Heart (British Cardiac Society)|August 10, 2017
Disease understanding in patients newly diagnosed with atrial fibrillationBrystana G Kaufman, Sunghee Kim, Karen Pieper, et al.
JAMA Cardiology|November 13, 2017
Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry StudyTaku Inohara, Peter Shrader, Karen Pieper, et al.
Heart (British Cardiac Society)|September 20, 2018
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillationTaku Inohara, Sunghee Kim, Karen Pieper, et al.
American Heart Journal|November 12, 2019
Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillationZak Loring, Peter Shrader, Larry A Allen, et al.
Journal of the American Heart Association|February 18, 2018
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)Benjamin A Steinberg, Peter Shrader, Karen Pieper, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Medical Devices (Auckland, N.Z.)|September 2, 2017
Can machine learning complement traditional medical device surveillance? A case study of dual-chamber implantable cardioverter-defibrillatorsJoseph S Ross, Jonathan Bates, Craig S Parzynski, et al.
The American Journal of Cardiology|February 4, 2021
Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry)Manan Pareek, Avinainder Singh, Lina Vadlamani, et al.
Circulation. Arrhythmia and Electrophysiology|April 17, 2020
Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AFBenjamin A Steinberg, DaJuanicia N Holmes, Karen Pieper, et al.
The American Journal of Cardiology|August 23, 2020
Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)Malini Madhavan, DaJuanicia N Holmes, Jonathan P Piccini, et al.
Circulation. Arrhythmia and Electrophysiology|December 14, 2019
Outcomes and Anticoagulation Use After Catheter Ablation for Atrial FibrillationJames V Freeman, Peter Shrader, Karen S Pieper, et al.
Heart (British Cardiac Society)|August 10, 2017
Disease understanding in patients newly diagnosed with atrial fibrillationBrystana G Kaufman, Sunghee Kim, Karen Pieper, et al.
JAMA Cardiology|November 13, 2017
Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry StudyTaku Inohara, Peter Shrader, Karen Pieper, et al.
Heart (British Cardiac Society)|September 20, 2018
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillationTaku Inohara, Sunghee Kim, Karen Pieper, et al.
American Heart Journal|November 12, 2019
Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillationZak Loring, Peter Shrader, Larry A Allen, et al.
Journal of the American Heart Association|February 18, 2018
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)Benjamin A Steinberg, Peter Shrader, Karen Pieper, et al.
Pageof 15